Next generation sequencing - a science tool or routine pathology?

Area of Science:

• Oncology
• Molecular Diagnostics
• Genomics

Background:

• Molecular assays for tumor translocation detection are increasingly used in diagnostics.
• Conventional methods like FISH and RT-PCR have limitations.
• Next-generation sequencing (NGS) offers comprehensive gene alteration detection.

Purpose of the Study:

• To evaluate the utility of NGS-based anchored multiplex PCR (Archer FusionPlex) in tumor diagnostics.
• To highlight its benefits over traditional methods for identifying molecular changes.
• To demonstrate its role in patient care, novel breakpoint discovery, and clinical trial stratification.

Main Methods:

• Utilized anchored multiplex PCR combined with next-generation sequencing (Archer FusionPlex Panels).
• Applied the technique for comprehensive molecular profiling of tumors.
• Focused on detecting gene alterations including point mutations and fusion genes.

Main Results:

• The NGS-based anchored multiplex PCR assay is fast and easy for routine labs.
• This technique effectively identifies targetable molecular changes in tumors.
• It aids in discovering novel fusion breakpoints and provides data for patient stratification.

Conclusions:

• NGS-based anchored multiplex PCR (Archer FusionPlex) is a valuable tool for tumor diagnostics.
• It enhances patient care by identifying actionable mutations and facilitating clinical trial enrollment.
• The method supports both routine diagnostics and the discovery of new tumor-specific molecular alterations.